论文部分内容阅读
目的：观察硫酸镁联合复方异丙托溴铵雾化吸入治疗小儿哮喘临床症状与肺功能恢复情况。方法将50例哮喘急性发作患儿随机分为硫酸镁联合复方异丙托溴铵溶液吸入组及单用复方异丙托溴铵吸入组，二组采用相同的综合性治疗，比较二组临床症状及肺功能指标的恢复，并进行统计学分析，同时观察其不良反应。结果硫酸镁联合复方异丙托溴铵溶液组在缓解症状及肺功能恢复方面明显优于单用复方异丙托溴铵组（P<0.05），且无明显不良反应。结论硫酸镁联合复方异丙托溴铵溶液雾化吸入治疗小儿哮喘急性发作疗效显著，且无明显的不良反应，安全，经济。“,”Objective Observe the symptoms and the lung function recovery in children with asthma that are treated by inhalation of magnesium sulfate combined with combivent ipratropium bromide. Methods Fifty children of acute asthma were randomly divided into the inhalation group of magnesium sulfate combined with combivent ipratropium bromide and the inhalation group of combivent ipratropium bromide. Two groups use the same comprehensive treatment. Compare the symptoms and the lung function recovery in two groups, then make statistical analysis and observe the adverse reactions. Results Compare with the single inhalation group, the combined group show superiority in al eviating symptoms and lung function recovery (P <0.05), and there is no adverse reaction. Conclusion Inhalation treatment with magnesium sulfate combined with combivent ipratropium bromide can cure asthma in children significantly, which is safe and economic and has no adverse reaction.